Stay updated on VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.

Latest updates to the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page shows a minor version update from Revision: v3.4.0 to Revision: v3.4.1 in the footer, with no changes to trial information or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check24 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4 on the page, indicating a minor site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations were updated to add new sites and revise the study's recruitment locations, including US locations and Región de Valparaíso (Chile). The page revision changed from v3.3.2 to v3.3.3.SummaryDifference1%

- Check74 days agoChange DetectedAdded a note clarifying that PubMed publications are automatically filled from PubMed and may not all relate to the study. Updated page revision to v3.3.2.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page no longer displays the government funding lapse notice, which is an administrative update and does not affect the trial details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check103 days agoChange DetectedThe new screenshot shows minor UI/layout tweaks and small copy edits; core study information such as eligibility criteria, interventions, outcomes, and listed locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.